$ATNM has several catalysts - both news and technical - which should lift this stock higher this week.

$ATNM was a big runner just a week ago and is still on lots of radars

They are presenting at ASCO this week

On Friday they announced positive data from Phase 1/2 Clinical Trials which will be discussed at ASCO

Horizontal Support is at $3.70 so there's roughly $0.25 of risk here at $3.94 closing price.

The first long term downtrend line was already pierced to the upside, and looks to be taken out on the next upside move.  Short term horizontal resistance is $4.30. 

Above that there is room for this stock to move to $5.50 on a big breakout.  This is where the short term uptrend line will converge with the long term downtrend line.